Hermetica Superfood Encyclopedia
The Short Answer
Glycitein is an isoflavone phytoestrogen found in soybeans that functions as a selective estrogen receptor modulator with anti-cancer properties. It works primarily through estrogen receptor binding and inhibition of protein kinases involved in cell proliferation pathways.
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelStrong
Primary Keywordglycitein benefits
Synergy Pairings3
Glycitein — botanical close-up
Health Benefits
Origin & History
Natural habitat
Glycitein is an O-methylated soy isoflavone (6-methoxy substitution) that accounts for 5-10% of total isoflavones found in soybeans and soy products. It originates from soy germ (Glycine max) and is typically extracted through advanced purification techniques or obtained during soy food processing.
“No historical or traditional medicine uses specific to glycitein were identified in the research. It occurs naturally as part of total soy isoflavone intake in traditional Asian diets but lacks documented traditional applications as an isolated compound.”Traditional Medicine
Scientific Research
Clinical evidence for glycitein alone is extremely limited. The only human trial identified was a phase I study (n=20 men with prostate cancer, n=6 controls) testing a soy isoflavone mixture containing glycitein at 300-600 mg genistein equivalents/day for 84 days, which showed no genotoxicity. Most evidence comes from preclinical cell culture and computational modeling studies.
Preparation & Dosage
Traditional preparation
No clinically studied dosage ranges for glycitein alone have been established. In the single human trial, glycitein was part of a soy isoflavone mixture delivering 300-600 mg genistein equivalents/day for 84 days. In vitro studies used 100 μg/mL for cytotoxic effects and 0.1-30 μmol/L for growth inhibition. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Glycitein is a minor soy isoflavone (phytoestrogen) belonging to the flavonoid subclass, constituting approximately 5-10% of total soy isoflavone content compared to genistein and daidzein which dominate. It is not a macronutrient or micronutrient itself but a bioactive polyphenolic compound. Molecular weight: 284.26 g/mol. Chemical structure: 7-hydroxy-6-methoxy-3-(4-hydroxyphenyl)-4H-chromen-4-one, distinguished from other soy isoflavones by a methoxy group at the C-6 position. Found in soy-based foods at concentrations of approximately 0.5-1.5 mg per 100g in whole soybeans, and up to 2-4 mg per 100g in some soy protein isolates. Present in three forms: aglycone (glycitein), glucoside conjugate (glycitin), and malonyl glucoside (6''-O-malonylglycitin). Bioavailability is moderate; intestinal microbiota hydrolyze glucoside forms to the active aglycone prior to absorption. Peak plasma concentrations typically reached within 4-8 hours post-ingestion. Demonstrates weak estrogenic activity (estimated 0.281% relative binding affinity compared to estradiol at ERα). No meaningful macro-, vitamin, mineral, or fiber content as it is a pure isolated phytochemical compound when studied.
How It Works
Mechanism of Action
Glycitein acts as a selective estrogen receptor modulator (SERM), binding to both ERα and ERβ receptors with varying affinities. It inhibits protein kinase C and tyrosine kinases involved in cell signaling cascades. The compound also modulates NF-κB pathways and induces apoptosis through caspase activation in cancer cells.
Clinical Evidence
Preclinical studies demonstrate glycitein's cytotoxic effects on breast carcinoma cells at 100 μg/mL concentrations. In vitro research shows anti-proliferative activity against colon cancer cells through multiple molecular pathways. Animal studies suggest cardiovascular protective effects through lipid metabolism modulation. However, human clinical trials are limited, and most evidence remains at the laboratory stage with unclear therapeutic dosing.
Safety & Interactions
Glycitein appears generally well-tolerated as part of soy food consumption in healthy adults. Potential interactions may occur with hormone-sensitive medications due to its estrogenic activity. Women with hormone-dependent cancers should exercise caution given its SERM properties. Safety during pregnancy and lactation has not been established through dedicated studies.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
7-(beta-D-glucopyranosyloxy)-6-methoxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one6-methoxy-7-glucosylgenistein6-methoxyisoflavonesoy isoflavone glyciteinglycitin aglycone6-methoxygenistein
Frequently Asked Questions
What foods contain glycitein naturally?
Glycitein is found primarily in soybeans and soy products like tofu, tempeh, and soy flour. Fermented soy products typically contain higher bioavailable concentrations due to bacterial conversion of glycitin to glycitein.
How much glycitein is in soy products?
Soy flour contains approximately 5-25 mg glycitein per 100g, while tofu contains 1-10 mg per 100g. Fermented products like miso can contain 10-50 mg per 100g depending on fermentation time and bacterial strains used.
Is glycitein the same as genistein?
No, glycitein and genistein are different isoflavone compounds with distinct molecular structures. Glycitein has a methoxy group at position 6, while genistein lacks this modification, resulting in different biological activities and receptor binding affinities.
Can glycitein help with menopause symptoms?
Limited research suggests glycitein's estrogenic activity may help with menopausal symptoms, but specific clinical trials are lacking. Most menopause research focuses on mixed isoflavone supplements rather than isolated glycitein compounds.
What is the optimal dosage of glycitein?
No established therapeutic dosage exists for isolated glycitein due to limited human trials. Typical dietary intake from soy foods provides 1-10 mg daily, while research studies have used concentrations ranging from 10-100 μg/mL in laboratory settings.
Does glycitein have any side effects or adverse reactions?
Glycitein is generally well-tolerated in supplement doses, as it is naturally present in commonly consumed soy foods. Most adverse effects reported in research are minimal, though some individuals may experience gastrointestinal symptoms typical of isoflavone supplementation, such as bloating or mild nausea. Long-term safety data in humans remains limited, so caution is advised in populations with specific health conditions or those taking estrogen-sensitive medications.
How does glycitein differ from other soy isoflavones like daidzein and genistein?
Glycitein is one of three major soy isoflavones, alongside genistein and daidzein, but comprises only 10-15% of total soy isoflavones compared to genistein's 40-50%. Unlike genistein, glycitein has received less research attention but shows distinct biological activity, particularly in smooth muscle cell inhibition and potential anti-cancer pathways. The three isoflavones have overlapping but non-identical mechanisms, meaning their combined presence in soy may provide complementary effects.
What does current scientific evidence say about glycitein's anti-cancer potential?
Preclinical laboratory studies demonstrate that glycitein exhibits cytotoxic effects on breast carcinoma cells and potential anti-proliferative activity in colon cancer models through multiple molecular pathways. However, this evidence is limited to in vitro (test tube) and animal studies, and no clinical trials in humans have confirmed these effects. More rigorous human research is needed before glycitein can be recommended as a cancer prevention or treatment agent.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w glycitein curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
